The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
Open accessAbstract
Injury or impaired clearance of apoptotic cells leads to the pathological accumulation of necrotic corpses, which induce an inflammatory response that initiates tissue repair. In addition, antigens present in necrotic cells can sometimes provoke a specific immune response and it has been argued that necrosis could explain adaptive immunity in seemingly infection-free situations, such as after allograft transplantation or in spontaneous and therapy-induced tumour rejection. In the mouse, the CD8alpha+ subset of dendritic cells phagocytoses dead cell remnants and cross-primes CD8+ T cells against cell-associated antigens. Here we show that CD8alpha+ dendritic cells use CLEC9A (also known as DNGR-1), a recently-characterized C-type lectin, to recognize a preformed signal that is exposed on necrotic cells. Loss or blockade of CLEC9A does not impair the uptake of necrotic cell material by CD8+ dendritic cells, but specifically reduces cross-presentation of dead-cell-associated antigens in vitro and decreases the immunogenicity of necrotic cells in vivo. The function of CLEC9A requires a key tyrosine residue in its intracellular tail that allows the recruitment and activation of the tyrosine kinase SYK, which is also essential for cross-presentation of dead-cell-associated antigens. Thus, CLEC9A functions as a SYK-coupled C-type lectin receptor to mediate sensing of necrosis by the principal dendritic-cell subset involved in regulating cross-priming to cell-associated antigens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The activation of caspases, a specific class of cysteine proteases has multiple effects on the immunogenicity of cell death 56”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis has traditionally been considered merely as an accidental, uncontrolled form of cell death that only occurs in pathological circumstances.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“There are several distinct subtypes of apoptosis that, although morphologically similar, can be triggered through different biochemical routes (for example, through the intrinsic or the extrinsic pathway or with or without caspase activation).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Necrosis is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Autophagic cell death occurs in the absence of chromatin condensation but is accompanied by massive autophagic vacuolization of the cytoplasm.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Apoptosis is accompanied by rounding-up of the cell, retraction of pseudopods, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), few or no ultrastructural modifications of cytoplasmic organelles, and plasma membrane blebbing but cell integrity is maintained until the final stages of the process.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“Furthermore, the apparent uniformity of apoptotic cell death may conceal heterogeneous functional aspects, such as whether or not dying apoptotic cells are recognized by the immune system 56.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [56]
In the citing paper
“CLeC9A has been shown to recognize necrotic cells and induce the cross-presentation of dead cell-associated antigens to CD8+ T cells.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
In the citing paper
“Therefore, it may be involved in regulating sterile immune responses, although the specific ligand recognized in this case is still unknown73,75.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
The Danger Model: A Renewed Sense of Self
Matzinger, P. (2002) · Science · doi:10.1126/science.1071059 · Cited by 4,205
Calreticulin exposure dictates the immunogenicity of cancer cell death
Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216
Apetoh, L., Ghiringhelli, F., Tesniere, A., Obeid, M., Ortiz, C., Criollo, A., Mignot, G., Maiuri, M. C., Ullrich, E., Saulnier, P., et al. (2007) · Nature Medicine · doi:10.1038/nm1622 · Cited by 3,056
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M. P., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,601
Brown, G. D., & Gordon, S. (2001) · Nature · doi:10.1038/35092620 · Cited by 1,579
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
Casares, N., Pequignot, M. O., Tesniere, A., Ghiringhelli, F., Roux, S., Chaput, N., Schmitt, E., Hamai, A., Hervas-Stubbs, S., Obeid, M., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050915 · Cited by 1,512
Sauter, B., Albert, M. L., Francisco, L. M., Larsson, M., Somersan, S., & Bhardwaj, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.423 · Cited by 1,357
LeibundGut-Landmann, S., Groß, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E., Tybulewicz, V., Brown, G. D., Ruland, J., et al. (2007) · Nature Immunology · doi:10.1038/ni1460 · Cited by 1,191
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 750
In Vitro Generation of Human XCR1+ Dendritic Cells from CD34+ Hematopoietic Progenitors
Balan, S., & Dalod, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3606-9_2 · Cited by 30
Helaoui, S., Boughattas, I., Mkhinini, M., Chebbi, L., Elkribi-Boukhris, S., Alphonse, V., Livet, A., Bannı, M., & Bousserrhıne, N. (2023) · Plant Stress · doi:10.1016/j.stress.2023.100212 · Cited by 30
Huynh, L., Wang, L., Shi, C., Park‐Min, K., & Ivashkiv, L. B. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102211 · Cited by 30
Airway Macrophage and Dendritic Cell Subsets in the Resting Human Lung
Patel, V. I., & Metcalf, J. P. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026459 · Cited by 32
Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy
Liu, Y., Yao, L., Cao, W., Liu, Y., Zhai, W., Wu, Y., Wang, B., Gou, S., Qin, Y., Qi, Y., et al. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.8b00811 · Cited by 29
Iberg, C. A., & Hawiger, D. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.05.037 · Cited by 28
Hoves, S., Sutton, V. R., Haynes, N. M., Hawkins, E. D., Fernandez‐Ruiz, D., Baschuk, N., Sedelies, K. A., Schnurr, M., Stagg, J., Andrews, D. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001670 · Cited by 29
Goritzka, M., Pereira, C., Makris, S., Durant, L. R., & Johansson, C. (2015) · Scientific Reports · doi:10.1038/srep18533 · Cited by 27
Liu, C., Zhu, J., Mi, Y., & Jin, T. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02663-z · Cited by 29
Chatterjee, F., & Spranger, S. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101710 · Cited by 31
Kepp, O., Gdoura, A., Martins, I., Panaretakis, T., Schlemmer, F., Tesnière, A., Fimia, G. M., Ciccosanti, F., Burgevin, A., Piacentini, M., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.15.12459 · Cited by 30
Transcriptional Regulation of Dendritic Cell Diversity
Chopin, M., Allan, R. S., & Belz, G. T. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00026 · Cited by 28
Dresch, C., Ackermann, M., Vogt, B., Pereira, B. D. A., Shortman, K., & Fraefel, C. (2011) · European Journal of Immunology · doi:10.1002/eji.201041374 · Cited by 27
Li, B., Yang, J., He, J., Peng, X., Zeng, Q., Song, Y., Xu, K., & Ma, H. (2021) · Genomics · doi:10.1016/j.ygeno.2021.05.025 · Cited by 27
DNGR-1-mediated cross-presentation of dead cell-associated antigens
Henry, C. M., Castellanos, C. A., & Sousa, C. R. E. (2023) · Seminars in Immunology · doi:10.1016/j.smim.2023.101726 · Cited by 28
Self-citationWilliams, M. A., Bauer, S. M., Lu, W., Guo, J., Walter, S., Bushnell, T. P., Lillehoj, E. P., & Georas, S. N. (2009) · Journal of Innate Immunity · doi:10.1159/000254790 · Cited by 27
Nair, P., Amsen, D., & Blander, J. M. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01251.x · Cited by 27
Unboxing dendritic cells: Tales of multi‐faceted biology and function
Giza, H., & Bozzacco, L. (2021) · Immunology · doi:10.1111/imm.13394 · Cited by 26
Clec12A, CD301b, and FcγRIIB/III define the heterogeneity of murine DC2s and DC3s
Amon, L., Seichter, A., Vurnek, D., Heger, L., Lächele, L., Tochoedo, N. R., Kaszubowski, T., Hatscher, L., Barańska, A., Tchitashvili, G., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113949 · Cited by 25
Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines
Zachová, K., Křupka, M., & Raška, M. (2015) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-015-0370-x · Cited by 26
Gargett, T., Grubor‐Bauk, B., Garrod, T. J., Yu, W., Miller, D. S., Major, L. D., Wesselingh, S. L., Suhrbier, A., & Gowans, E. J. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.93 · Cited by 26
Grubor‐Bauk, B., Yu, W., Wijesundara, D. K., Gummow, J., Garrod, T. J., Brennan, A. J., Voskoboinik, I., & Gowans, E. J. (2015) · Gene Therapy · doi:10.1038/gt.2015.86 · Cited by 26
Identification of novel loci for the generation of reporter mice
Rizzi, N., Rebecchi, M., Levandis, G., Ciana, P., & Maggi, A. C. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1142 · Cited by 25
Understanding and Modulating Immunity With Cell Reprogramming
Pires, C. F., Rosa, F. A., Kurochkin, I., & Pereira, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02809 · Cited by 25
Thom, J. T., Walton, S. M., Torti, N., & Oxenius, A. (2013) · European Journal of Immunology · doi:10.1002/eji.201343992 · Cited by 25
A dual role for genetically modified lymphocytes in cancer immunotherapy
Russo, V. E. A., Bondanza, A., Ciceri, F., Bregni, M., Bordignon, C., Traversari, C., & Bonini, C. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.003 · Cited by 25
Taking off the brakes: T cell immunity in the liver
Kern, M., Popov, A., Kurts, C., Schultze, J. L., & Knolle, P. A. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.001 · Cited by 26
Tissue-Specific Diversity and Functions of Conventional Dendritic Cells
Pakalniškytė, D., & Schraml, B. U. (2017) · Advances in immunology · doi:10.1016/bs.ai.2017.01.003 · Cited by 27
Serological biomarkers for management of primary sclerosing cholangitis
Tornai, D., Ven, P. L., Lakatos, P. L., & Papp, M. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i21.2291 · Cited by 24
Hussain, Z. B., Zhang, Y., Qiu, L., Gou, S., & Liu, K. (2025) · npj Vaccines · doi:10.1038/s41541-025-01084-2 · Cited by 26
Cellular and molecular targeting for nanotherapeutics in transplantation tolerance
Hlavaty, K. A., Luo, X., Shea, L. D., & Miller, S. D. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.03.013 · Cited by 24
Having an Old Friend for Dinner: The Interplay between Apoptotic Cells and Efferocytes
Lam, A. L., & Heit, B. (2021) · Cells · doi:10.3390/cells10051265 · Cited by 22
Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity
Xu, F., Wang, Z., Zhang, H., Chen, J., Wang, X., Cui, L., Xie, C., Li, M., Wang, F., Zhou, P., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-3977 · Cited by 24
Hänel, G., Angerer, C., Petry, K., Lichtenegger, F. S., & Subklewe, M. S. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03109-w · Cited by 24
Increase in DNA vaccine efficacy by virosome delivery and co‐expression of a cytolytic protein
Gargett, T., Grubor‐Bauk, B., Miller, D. S., Garrod, T. J., Yu, W., Wesselingh, S. L., Suhrbier, A., & Gowans, E. J. (2014) · Clinical & Translational Immunology · doi:10.1038/cti.2014.13 · Cited by 24
Timing is everything: dendritic cell subsets in murine Leishmania infection
Ashok, D., & Acha‐Orbea, H. (2014) · Trends in Parasitology · doi:10.1016/j.pt.2014.08.001 · Cited by 24
Siqueira, I. M., Wüthrich, M., Li, M., Wang, H., Las-Casas, L. D. O., de Castro, R. J. A., Klein, B. S., & Bocca, A. L. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008386 · Cited by 25
Sittig, S. P., de Vries, I. J. M., & Schreibelt, G. (2015) · Biomedicines · doi:10.3390/biomedicines3040282 · Cited by 23
Sorrentino, C., Yin, Z., Ciummo, S. L., Lanuti, P., Lu, L., Marchisio, M., Bellone, M., & Carlo, E. D. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0668-z · Cited by 23
Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors
Wijfjes, Z., van Dalen, F. J., Gall, C. M. L., & Verdoes, M. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.3c00330 · Cited by 23
Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis
Sasaki, I., Kato, T., Hemmi, H., Fukuda‐Ohta, Y., Wakaki-Nishiyama, N., Yamamoto, A., & Kaisho, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.857954 · Cited by 22
Omahdi, Z., Horikawa, Y., Nagae, M., Toyonaga, K., Imamura, A., Takato, K., Teramoto, T., Ishida, H., Kakuta, Y., & Yamasaki, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012491 · Cited by 22
Ohara, R. A., & MURPHY, K. M. M. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102350 · Cited by 21
The Evolving Role of Dendritic Cells in Atherosclerosis
Britsch, S., Langer, H. F., Duerschmied, D., & Becher, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042450 · Cited by 21
León, B. (2025) · Trends in Immunology · doi:10.1016/j.it.2024.12.005 · Cited by 21
Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2
Jo, S., Ohara, R. A., Theisen, D. J., Kim, S. K., Liu, T., Bullock, C. B., He, M., Ou, F., Chen, J., Piersma, S. J., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20240955 · Cited by 21
Into the Intracellular Logistics of Cross-Presentation
Neefjes, J., & Sadaka, C. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00031 · Cited by 22
Verco, S. J., Maulhardt, H. A., Baltezor, M. J., Williams, E., Iacobucci, M. A., Wendt, A., Verco, J., Marin, A. M., Campbell, S., Dorman, P., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00868-4 · Cited by 21
Gall, C. M. L., Cammarata, A., de Haas, L., Ramos‐Tomillero, I., Cuenca‐Escalona, J., Schouren, K., Wijfjes, Z., Becker, A. M. D., Bödder, J., Dölen, Y., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004309 · Cited by 21
Ginhoux, F., Ng, L. G., & Mérad, M. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_115 · Cited by 21
Can Dendritic Cell Vaccination Prevent Leukemia Relapse?
O’Brien, L., Guillerey, C., & Radford, K. J. (2019) · Cancers · doi:10.3390/cancers11060875 · Cited by 21
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming
Luri‐Rey, C., Gomis, G., Glez‐Vaz, J., Manzanal, A., Riaño, A. M., Rodriguez-Ruiz, M. E., Teijeira, Á., & Melero, I. (2023) · Immunological Reviews · doi:10.1111/imr.13281 · Cited by 23
Welzen‐Coppens, J. M. C., van Helden-Meeuwsen, C. G., Leenen, P. J. M., Drexhage, H. A., & Versnel, M. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0312168 · Cited by 20
Macrophages and Recently Identified Forms of Cell Death
Sanz, A. B., Sánchez-Niño, M. D., Izquierdo, M. C., González–Espinoza, L., Ucero, A. C., Poveda, J., Ruiz‐Andrés, O., Ruiz‐Ortega, M., Selgas, R., Egido, J., et al. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.771183 · Cited by 20
Myeloid and Plasmacytoid Dendritic Cells and Cancer – New Insights
Gulubova, M. V., Ivanova, K. V., Hadzhi, M., Chonov, D., Ignatova, M. M., & Ananiev, J. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.735 · Cited by 20
Lipid nanoparticles as a tool to dissect dendritic cell maturation pathways
Rennen, S., Bosteels, V., Nolf, C. D., Maréchal, S., Vetters, J., Lil, K. V., Webb, G. R., Swinnen, J., Velde, E. V. D., Fayazpour, F., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116150 · Cited by 20
Enhanced Immunogenicity of Mitochondrial-Localized Proteins in Cancer Cells
Prota, G., Gileadi, U., Rei, M., Lechuga‐Vieco, A. V., Chen, J., Galiani, S., Bedard, M., Lau, V. W. C., Fanchi, L. F., Artibani, M., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0467 · Cited by 18
Dendritic cell functions in vivo: A user's guide to current and next‐ generation mutant mouse models
Dalod, M., & Scheu, S. (2022) · European Journal of Immunology · doi:10.1002/eji.202149513 · Cited by 19
Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells
Mi, H., Soni, B., Schwalie, P. C., Hüsser, T., Waltzinger, C., Silva, D. D., Prinz, Y., Krümpelmann, L., Calabrό, S., de Matos, I. G., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004268 · Cited by 19
Cuevas, E. S., Valladeau‐Guilemond, J., Mouret, S., Roubinet, B., de Fraipont, F., Landemarre, L., Charles, J., Bendriss‐Vermare, N., Chaperot, L., & Aspord, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1040600 · Cited by 22
Tsunetsugu‐Yokota, Y., & Muhsen, M. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00178 · Cited by 23
Deciphering the heterogeneity of myeloid cells during neuroinflammation in the single‐cell era
Borst, K., & Prinz, M. (2020) · Brain Pathology · doi:10.1111/bpa.12910 · Cited by 17
FcRn regulates antigen presentation in dendritic cells downstream of DEC205-targeted vaccines
Macri, C., Paxman, M., Jenika, D., Lin, X. P., Elahi, Z., Gleeson, P. A., Caminschi, I., Lahoud, M. H., Villadangos, J. A., & Mintern, J. D. (2024) · npj Vaccines · doi:10.1038/s41541-024-00854-8 · Cited by 18
Targeting NINJ1-mediated cell rupture to treat inflammatory diseases
Hur, C. J., & Steinberg, B. E. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01113-9 · Cited by 20
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy
Galán, M., Fernández‐Méndez, L., Núñez, V., Femenía-Muiña, M., Figuera-Belmonte, P., Moya-Ruiz, E., Martínez-Cano, S., Hernández-García, E., Rodrigo-Tapias, M., Rodríguez-Ronchel, A., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.325792 · Cited by 18
Self-citationShaw, S. M., Middleton, J., Wigglesworth, K., Charlemagne, A., Schulz, O., Glossop, M. S., Whalen, G. F., Old, R. W., Westby, M., Pickford, C., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1059-8 · Cited by 18
Myeloid cells in sensing of tissue damage
del Fresno, C., & Sancho, D. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.006 · Cited by 16
Self-citationHenry, C. M., Castellanos, C. A., Buck, M. D., Giampazolias, E., Frederico, B., Cardoso, A., Rogers, N. C., Schulz, O., Lee, S., Canton, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113506 · Cited by 19
Self-citationZhou, M., Li, W., Wen, Z., Sheng, Y., Ren, H., Dong, H., Cao, M., Hu, H., & Wang, L. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.10.015 · Cited by 18
Bridging Innate and Adaptive Antitumor Immunity Targeting Glycans
Pashov, A. D., Monzavi‐Karbassi, B., Raghava, G. P. S., & Kieber‐Emmons, T. (2010) · BioMed Research International · doi:10.1155/2010/354068 · Cited by 18
Patel, V. I., & Metcalf, J. P. (2016) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000072 · Cited by 20
Twilhaar, M. K. N., Czentner, L., Bouma, R. G., Olesek, K., Grabowska, J. A., Wang, A. Z., Affandi, A. J., Belt, S. C., Kalay, H., van Nostrum, C. F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.842241 · Cited by 17
Cui, T. X., Maheshwer, B., Hong, J. Y., Goldsmith, A. M., Bentley, J. K., & Popova, A. P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501116 · Cited by 18
Doepker, L. E., White, J., Cambier, J. C., Kappler, J. W., & Marrack, P. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501565 · Cited by 17
Mind the Map: Technology Shapes the Myeloid Cell Space
Günther, P. S., & Schultze, J. L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02287 · Cited by 17
Autenrieth, S. E., Grimm, S., Rittig, S. M., Grünebach, F., Gouttefangeas, C., & Bühring, H. (2015) · Clinical & Translational Immunology · doi:10.1038/cti.2015.29 · Cited by 18
Childs, E., Henry, C. M., Canton, J., & Sousa, C. R. E. (2021) · Open Biology · doi:10.1098/rsob.210194 · Cited by 17
Self-citationVariegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State
Bourque, J., & Hawiger, D. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100932 · Cited by 17
Nanotechnological Approaches to Immunosuppression and Tolerance Induction
Patel, K., Atkinson, C., Tran, D. T., & Nadig, S. N. (2017) · Current Transplantation Reports · doi:10.1007/s40472-017-0146-9 · Cited by 17
Vaccinia Virus: Mechanisms Supporting Immune Evasion and Successful Long-Term Protective Immunity
Hsu, J., Kim, S., & Anandasabapathy, N. (2024) · Viruses · doi:10.3390/v16060870 · Cited by 18
The role of NK cells in regulating tumorimmunity: current state, challenges and future strategies
Zhu, W., Fan, C., Zhao, Y., Li, W., Niu, J., Dong, S., Yang, Z., & Zhou, W. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03980-y · Cited by 17
Brabants, E., Heyns, K., Smet, S., Devreker, P., Ingels, J., Cabooter, N. D., Debacker, V., Dullaers, M., van Meerbeeck, J. P., Vandekerckhove, B., et al. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.06.006 · Cited by 16
Zhao, Z., Zhao, Q. P., Hu, C., Chen, F., Wang, F., Tang, H., Xia, H., Zhou, Y., & Sun, Y. (2023) · International Journal of Oral Science · doi:10.1038/s41368-023-00234-3 · Cited by 16
Sattler, S., Ghadially, H., Reiche, D., Karas, I., & Hofer, E. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02433.x · Cited by 16
Bühligen, J., Himmel, M., Gebhardt, C., Simon, J. C., Ziegler, W. H., & Averbeck, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22301 · Cited by 16
Pereira, F. V., de Melo, A. C. L., de Melo, F. M., Mourão‐Sá, D., Silva, P., Berzaghi, R., Herbozo, C. D. A., Coelho-dos-Reis, J. G. A., Scutti, J. A. B., Origassa, C. S. T., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178420 · Cited by 16
Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity
Xie, B., Yuan, B., Zhao, X., Xie, T., Li, R., Wei, P., Sun, Q., Hu, W., Pan, B., Chen, Y., et al. (2025) · Science · doi:10.1126/science.ady5362 · Cited by 16
Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo
Bourque, J., & Hawiger, D. (2022) · Antibodies · doi:10.3390/antib11010008 · Cited by 14
Xiao, H., Ulmert, I., Bach, L., Huber, J. E., Narasimhan, H., Kurochkin, I., Chang, Y., Holst, S., Mörbe, U., Zhang, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46966-6 · Cited by 15
The Role of NADPH Oxidase 2 in Leukocytes
Leiding, J. W., Mathews, C. E., Arnold, D. E., & Chen, J. (2025) · Antioxidants · doi:10.3390/antiox14030309 · Cited by 18
Joubert, P.-E., & Albert, M. L. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00061 · Cited by 16
Cross-presentation of Exogenous Antigens
Li, B., & Hu, L. (2019) · Transfusion Clinique et Biologique · doi:10.1016/j.tracli.2019.01.006 · Cited by 15
Rizzetto, L., Filippo, C. D., Rivero, D., Riccadonna, S., Beltrame, L., & Cavalieri, D. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.07.002 · Cited by 16
Fu, Y. C., Das, A., Wang, D., Braun, R., & Yi, R. (2024) · Genome biology · doi:10.1186/s13059-024-03299-3 · Cited by 13
Rückrich, T., & Steinle, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453548 · Cited by 16
Immunoglobulins drive terminal maturation of splenic dendritic cells
Ziętara, N., Łyszkiewicz, M., Puchałka, J., Pei, G., Gutierrez, M. G., Lienenklaus, S., Hobeika, E., Reth, M. G., dos Santos, V. A. P. M., Krueger, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210654110 · Cited by 14
The C-type lectin-like receptors of Dectin-1 cluster in natural killer gene complex
Xie, J. (2012) · Glycoconjugate Journal · doi:10.1007/s10719-012-9419-9 · Cited by 14
DNGR‐1 is dispensable for CD8+ T‐cell priming during respiratory syncytial virus infection
Durant, L. R., Pereira, C., Boakye, A., Makris, S., Kausar, F., Goritzka, M., & Johansson, C. (2014) · European Journal of Immunology · doi:10.1002/eji.201444454 · Cited by 14
Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
Lahoud, M. H., & Radford, K. J. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1873056 · Cited by 14
Mapping intratumor heterogeneity across layers for advancing immunotherapy
Marine, J., Bartok, O., Sagie, S., Vitiello, P. P., Bardelli, A., Weller, C., Chang, T., Tonelli, C., Spranger, S., Ruppin, E., et al. (2026) · Cell · doi:10.1016/j.cell.2026.03.025 · Cited by 16
Metadata
- Authors
- Sancho, D., Joffre, O. P., Keller, A. M., Rogers, N. C., Martínez, D., Hernanz-Falcón, P., Rosewell, I., & Sousa, C. R. E.
- Affiliations
- The Honourable Society of Lincoln's Inn (GB)
- Cancer Research UK (GB)
- Corresponding author
- Sousa, Caetano Reis e
- Venue
- Nature
- Published
- 2009-04
- Volume
- 458
- Issue
- 7240
- Pages
- 899-903
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC2671489
- OpenAlex
- W2136883776
- Cited by
- 750
- References
- 27
- Citations by year
- 2026: 17 · 2025: 35 · 2024: 31 · 2023: 44 · 2022: 45 · 2021: 39 · 2020: 44 · 2019: 38 · 2018: 37 · 2017: 30 · 2016: 47 · 2015: 49 · 2014: 54 · 2013: 55 · 2012: 61
- FWCI
- 26.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Cancer Research UK (A3598)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- CLEC9A, DNGR-1, C-type lectin receptors, dendritic cells, CD8α+ dendritic cells, necrosis, cross-presentation, Syk, immunogenicity, tissue repair, inflammation, allograft rejection, tumor rejection
- MeSH terms
- Animals, Cells, Cultured, Dendritic Cells, Humans, Ligands, Necrosis, Phagocytosis, Receptors, Immunologic, Receptors, Mitogen, Signal Transduction, CD8 Antigens, CD8-Positive T-Lymphocytes, Lectins, C-Type, Cross-Priming, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
